# GenFlow Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genflow-biosciences

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.genflowbio.com
- Latest round: Seed (Jan 15, 2021)
- Investors on record: 1

## About

Based in London, UK, and founded in 2020, GenFlow Biosciences PLC is a biotechnology company specializing in the field of longevity science and the development of gene therapies aimed at mitigating the impacts of aging and diseases linked to old age through therapeutic approaches. As of 2023, the company is led by its CEO, Eric Leire. In January 2021, GenFlow Biosciences PLC raised seed funding from the Longevity Tech Fund. 

The company focuses on anti-aging treatments and conducts research in the field of longevity. Their product range comprises GF-1002, GF-3001, and GF-4001, aimed at addressing the consequences of aging, potentially delaying or stopping the aging process, lowering the occurrence of age-related illnesses, and consequently extending lifespan.

## Funding rounds

- Seed, Jan 15, 2021 — Longevity Tech Fund

## Investors

- Longevity Tech Fund (https://capitalatlas.ai/funds/longevity-tech-fund) — Seed